Evidence map›Paper›PMID 41044326›Full record

ArticleScientific reports2025

Photothermal therapy and radiotherapy of Bi

Faranak Saghatchi, Farshid Babapour Mofrad, Hossein Danafar, Elham Saeedzadeh, Mojtaba Salouti

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Faranak SaghatchiDepartment of Medical Radiation Engineering, SR.C., Islamic Azad University, Tehran, Iran.
Farshid Babapour MofradDepartment of Medical Radiation Engineering, SR.C., Islamic Azad University, Tehran, Iran. babapour@iau.ac.ir.
Hossein DanafarDepartment of Medicinal Chemistry School of Pharmacy Zanjan University of Medical Sciences, Zanjan, Iran. danafar@zums.ac.ir.
Elham SaeedzadehDepartment of Medical Radiation Engineering, SR.C., Islamic Azad University, Tehran, Iran.
Mojtaba SaloutiNanobiotechnology Research Center, Za.C., Islamic Azad University, Zanjan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiotherapy (RT) is one of the main methods of breast cancer treatment that can be used alone or together with other therapy methods. Also, photothermal therapy (PTT) has attracted attention as another modality in tumor treatment. Recently, combination therapy has been proposed as a new alternative approach to increase the effectiveness of cancer therapy. On the other side, the investigations on the use of metal-based hybrid nanoparticles (MHNs) simultaneously as a radiosensitizer and a photothermal agent in the case of combination of RT and PTT have been increased to enhance the efficiency of cancer treatment too. In this research, Bi

Indexed as

BismuthBreast NeoplasmsGoldMetal NanoparticlesNanotubesPhotothermal TherapySulfidesCell Line, TumorCell SurvivalCombined Modality TherapyFemaleHumansRadiation-Sensitizing AgentsBismuthbismuth sulfideGoldRadiation-Sensitizing AgentsSulfidesBi2S3 NPsBreast cancerCombination therapyGNRsMHNsPhotothermal therapyRadiotherapy

Identifiers

PMID41044326
PMCPMC12494745

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.